Necrotizing Enterocolitis in Newborns

Necrotizing enterocolitis (NEC) is primarily a disease process of the gastrointestinal (GI) tract of premature neonates that results in inflammation and bacterial invasion of the bowel wall. Despite advances in the care of premature infants, NEC remains one of the leading causes of morbidity and mortality in this population. It occurs in 1–5% of all neonatal intensive care admissions and 5–10% of all very low birthweight (<1500 g) infants. Although research has presented an interesting array of potential contributing factors, the precise aetiology of this multifactorial disease process remains elusive. Historically, it was believed that NEC arose predominantly from ischaemic injury to the immature GI tract, yet alternate plausible hypotheses indicate that many factors are likely to be involved. These may include issues related to the introduction and advancement of enteric feeding, alterations in the normal bacterial colonization of the GI tract, bacterial translocation and activation of the cytokine cascade, decreased epidermal growth factor, increased platelet activating factor, and mucosal damage from free radical production.Clinical manifestations of NEC may be vague, including increased episodes of apnoea, desaturations, bradycardia, lethargy and temperature instability. There may also be GI-specific symptoms such as feeding intolerance, emesis, bloody stools, abdominal distention and tenderness, and abdominal wall discolouration. Laboratory values may be indicative of infection, coagulation abnormalities and fluid retention. Radiographic signs may include ileus, dilated or fixed intestinal loops, air in the intestinal wall or free air in the abdomen. Medical treatment typically consists of bowel rest and decompression, antibacterial therapy, and management of other haematological or electrolyte imbalances. Increased respiratory and cardiovascular support is sometimes needed. In neonates who do not respond adequately to medical management, or if pneumoperitoneum is present, surgical intervention may occur with either use of a peritoneal drain or laparotomy.Advances in antenatal and neonatal care have resulted in increased survival of extremely preterm neonates. As this at-risk population continues to increase, an effective preventative strategy for NEC is needed. One preventative strategy is the use of antenatal corticosteroids to enhance maturation of the fetus if preterm delivery is likely. Recommendation of use of breast milk, early initiation of trophic feeds and judicoius advancement of enteric feeds are current postnatal strategies. Other preventative strategies that have been investigated include the use of oral antibacterials, antioxidants, supplementation of arginine and epidermal growth factor, none of which have changed clinical practice. Recent promising data indicate that prophylactic use of probiotics may play a role in preventing the onset of NEC. However, more large-scale, definitive studies are needed.

[1]  T. O'Shea,et al.  Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants , 2007, Journal of Perinatology.

[2]  W. Oh,et al.  Oral Probiotics Reduce the Incidence and Severity of Necrotizing Enterocolitis in Very Low Birth Weight Infants , 2005, Pediatrics.

[3]  C. Costalos,et al.  Enteral feeding of premature infants with Saccharomyces boulardii. , 2003, Early human development.

[4]  D. Zelterman,et al.  Laparotomy versus peritoneal drainage for necrotizing enterocolitis and perforation. , 2006, The New England journal of medicine.

[5]  R. Kliegman Models of the pathogenesis of necrotizing enterocolitis , 1990, The Journal of Pediatrics.

[6]  T. Cole,et al.  Breast milk and neonatal necrotising enterocolitis , 1990, The Lancet.

[7]  A. Pierro,et al.  Resection and primary anastomosis is a valid surgical option for infants with necrotizing enterocolitis who weigh less than 1000 g. , 2005, Archives of surgery.

[8]  G. Fick,et al.  Plasma L-arginine concentrations in premature infants with necrotizing enterocolitis. , 1997, The Journal of pediatrics.

[9]  H. Harmsen,et al.  Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. , 2000, Journal of pediatric gastroenterology and nutrition.

[10]  G. Fick,et al.  Arginine supplementation prevents necrotizing enterocolitis in the premature infant. , 2002, The Journal of pediatrics.

[11]  A. Kunz,et al.  Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. , 2004, Journal of pediatric gastroenterology and nutrition.

[12]  R. McCuskey,et al.  Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[13]  A. Leonard,et al.  Ontogeny of salivary epidermal growth factor and necrotizing enterocolitis. , 2007, The Journal of pediatrics.

[14]  O. Goulet,et al.  Short bowel syndrome and intestinal transplantation in children , 2006, Current opinion in clinical nutrition and metabolic care.

[15]  D. Tudehope,et al.  Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. , 2001, The Cochrane database of systematic reviews.

[16]  M. J. Bell,et al.  Neonatal Necrotizing Enterocolitis: Therapeutic Decisions Based upon Clinical Staging , 1978, Annals of surgery.

[17]  I. Holzman,et al.  Necrotising enterocolitis: The state of the science , 2007, Indian journal of pediatrics.

[18]  G. Valencia,et al.  Platelet-activating factor in infants at risk for necrotizing enterocolitis. , 2001, The Journal of pediatrics.

[19]  B. Efron,et al.  A meta-analysis of peritoneal drainage versus laparotomy for perforated necrotizing enterocolitis. , 2001, Journal of pediatric surgery.

[20]  B. Warner,et al.  Role of epidermal growth factor in the pathogenesis of neonatal necrotizing enterocolitis. , 2005, Seminars in pediatric surgery.

[21]  D. Hackam,et al.  THE ROLE OF THE INTESTINAL BARRIER IN THE PATHOGENESIS OF NECROTIZING ENTEROCOLITIS , 2007, Shock.

[22]  W. Poole,et al.  Laparotomy Versus Peritoneal Drainage for Necrotizing Enterocolitis or Isolated Intestinal Perforation in Extremely Low Birth Weight Infants: Outcomes Through 18 Months Adjusted Age , 2006, Pediatrics.

[23]  P. Panigrahi Necrotizing Enterocolitis , 2006, Paediatric drugs.

[24]  S. Eaton,et al.  Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis , 2006, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[25]  R. Kliegman,et al.  Neonatal necrotizing enterocolitis: Pathogenesis, classification, and spectrum of illness , 1987, Current Problems in Pediatrics.

[26]  C. Dani,et al.  Probiotics Feeding in Prevention of Urinary Tract Infection, Bacterial Sepsis and Necrotizing Enterocolitis in Preterm Infants , 2002, Neonatology.

[27]  J. Simes,et al.  Enteral human IgG for prevention of necrotising enterocolitis: a placebo-controlled, randomised trial , 2001, The Lancet.

[28]  M. Millar,et al.  Probiotics for preterm infants? , 2003, Archives of disease in childhood. Fetal and neonatal edition.

[29]  Guoyao Wu,et al.  Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. , 2000 .

[30]  W. Carlo,et al.  Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. , 1997, Pediatrics.

[31]  M. Caplan,et al.  Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. , 2005, The Journal of pediatrics.

[32]  M. Henry,et al.  Laparotomy Versus Peritoneal Drainage for Perforated Necrotizing Enterocolitis , 2006 .

[33]  M. Henry,et al.  Current issues in the management of necrotizing enterocolitis. , 2004, Seminars in perinatology.

[34]  Kim Updegrove Necrotizing Enterocolitis: the Evidence for Use of Human Milk in Prevention and Treatment , 2004, Journal of Human Lactation.

[35]  R. Falcone,et al.  Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. , 2000, Journal of pediatric surgery.

[36]  J. Gerstle,et al.  Correlation of sonographic findings and outcome in necrotizing enterocolitis , 2007, Pediatric Radiology.

[37]  J. Gerstle,et al.  Necrotizing enterocolitis: review of state-of-the-art imaging findings with pathologic correlation. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[38]  B. Stoll,et al.  Necrotising enterocolitis , 2006, The Lancet.

[39]  C. Hammerman,et al.  Germ warfare: probiotics in defense of the premature gut. , 2004, Clinics in perinatology.

[40]  George Tomlinson,et al.  Necrotizing enterocolitis: assessment of bowel viability with color doppler US. , 2005, Radiology.

[41]  A. Hebra,et al.  Necrotizing enterocolitis in infants with very low birth weight. , 2000, Seminars in pediatric surgery.

[42]  P. Pemberton,et al.  Primary anastomosis for necrotising enterocolitis: a 12-year experience. , 1989, Journal of pediatric surgery.

[43]  J. Goldsmith,et al.  Sonographic detection of portal venous gas in infants with necrotizing enterocolitis. , 1984, AJR. American journal of roentgenology.

[44]  Shripada Rao,et al.  Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials , 2007, The Lancet.

[45]  T. Fok,et al.  Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants , 1998, Archives of disease in childhood. Fetal and neonatal edition.

[46]  M. Caplan,et al.  Neonatal Necrotizing Enterocolitis: Clinical Considerations and Pathogenetic Concepts , 2002, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[47]  N. Wright,et al.  Intestinal mucosa remodeling by recombinant human epidermal growth factor(1-48) in neonates with severe necrotizing enterocolitis. , 2007, Journal of pediatric surgery.

[48]  J. Scanlon,et al.  Oral gentamicin therapy in the prevention of neonatal necrotizing enterocolitis. A controlled double-blind trial. , 1978, American journal of diseases of children.

[49]  R. Polin,et al.  Treatment and prevention of necrotizing enterocolitis , 2003, Seminars in Neonatology.

[50]  T. O'Shea,et al.  Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants , 2007, Journal of Perinatology.

[51]  L. Brion,et al.  Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates. , 2006, The Cochrane database of systematic reviews.

[52]  C. Costalos,et al.  The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants. , 2007, Early human development.

[53]  G. Gibson,et al.  Probiotics and prebiotics in infant nutrition , 2007, Proceedings of the Nutrition Society.

[54]  C. Berseth Gestational evolution of small intestine motility in preterm and term infants. , 1989, The Journal of pediatrics.

[55]  M. Walsh,et al.  Severity of necrotizing enterocolitis: influence on outcome at 2 years of age. , 1989, Pediatrics.

[56]  C. Berseth,et al.  Prolonging small feeding volumes early in life decreases the incidence of necrotizing enterocolitis in very low birth weight infants. , 2003, Pediatrics.